Schonfeld Strategic Advisors LLC Eledon Pharmaceuticals, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $13.8 Billion
- Q3 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 1,500,000 shares of ELDN stock, worth $6.32 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,500,000
Previous 1,500,000
-0.0%
Holding current value
$6.32 Million
Previous $3.96 Million
5.68%
% of portfolio
0.03%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding ELDN
# of Institutions
34Shares Held
18.4MCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA6.29MShares$26.5 Million0.5% of portfolio
-
Armistice Capital, LLC New York, NY2.36MShares$9.95 Million0.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.57MShares$6.59 Million0.0% of portfolio
-
Zimmer Partners, LP New York, NY1.43MShares$6.04 Million0.07% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L31.3MShares$5.46 Million0.59% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $57.9M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...